Campari Group (BIT: CPR) reports organic net revenue growth below 4.0% for January–September 2026 in its 9-month revenue update (approx. October 29, 2026)
Pending
✦ AI-generated prediction
Published on 30. September 2026
·
Predicted for 29. October 2026
·
Based on: Historical Cycle
Campari Group (Aperol, Campari, Grand Marnier, SKYY Vodka) traditionally releases its 9-month revenue update in late October (2025: October 30). The premium spirits environment in 2026 is challenged: Pernod Ricard and Diageo are forecast in open Cassandra predictions to report organic growth below 2% for Q1 FY2027; Rémy Cointreau below 5% for H1 FY2027. Campari's US business faces continued on-trade consumer caution; the Aperol Spritz boom in Europe shows saturation signs. In the 9M-2025 update, Campari grew only +0.8% organically. No Polymarket market exists for this question; the sectoral trend supports a sub-4% outcome.
Data basis for this prediction
- Campari Group 9M-2025-Umsatzbericht, 30. Oktober 2025: organisches Wachstum +0,8 % (Campari Investor Relations)
- Cassandra.news offene Vorhersagen: Pernod Ricard <2 % (15. Okt.) / Diageo <2 % (5. Nov.) / Rémy Cointreau <5 % (27. Nov.)
- S&P Global / Euromonitor: Premium-Spirituosenmarkt Europa & USA — anhaltende Nachfrageschwäche 2026
- Campari Group Investor Relations Finanzkalender: 9M-Umsatzupdate ca. 29. Oktober 2026
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
🍾 Beverages
✦ AI
Q1 FY2027 (April–June 2026) showed Rémy Cointreau with +1.3% organic growth on revenue of €223.2 million — a weak but positive recovery from the −8.7% collapse in H1 FY2026. The company reaffirmed full-year guidance of 'high single-digit' organic growth for FY2027, implying significant acceleration in Q2–Q4. For Q2 FY2027 (July–September 2026), key headwinds persist: (1) China — the primary cognac market — continues to suffer from subdued consumer confidence and MOFCOM anti-dumping tariffs on EU spirits (in force since October 2024); (2) US demand for premium cognac is moderating; (3) Rémy deliberately cut distillation capacity in 2023-25. The H1 growth rate is likely between Q1 (+1.3%) and the required H2 ramp-up — a figure above 5% for H1 would require a markedly strong Q2 (>+8%). Probability below 5%: approximately 62%. No Polymarket contract available.
🍾 Beverages
✦ AI
Diageo reported FY2026 (ended June 2026) organic net revenue growth of −2.0%, further deteriorating from −0.6% in FY2025. Structural headwinds are broad: North America (organic −5%, premium spirits downturn in whisky and tequila) and Asia Pacific (organic −4%, China normalization after COVID catch-up effects) dominate the picture. Q1 FY2027 (July–September 2026) faces the same macro backdrop: the Fed continues raising rates to 4.00–4.25% (open Cassandra prediction), dampening discretionary premium spending. Pernod Ricard is also predicted to report below 2% organic growth for the same period. A recovery to ≥2% in Q1 FY2027 appears unrealistic. No Polymarket/Kalshi equivalent.
🍾 Beverages
✦ AI
Pernod Ricard's FY2026 annual results (August 27, 2026) showed organic net revenue growth of −3%; US −14%, operating profit −17.9%, FCF €1.2bn. Structural headwinds persist for Q1 FY2027: weak Chinese consumer demand, US tariff exposure on Scotch whisky and Cognac, and a reversal in premiumisation trends. Competitor Diageo also reported −27.2% adjusted operating profit and −8.4% North America organic sales in FY2026. A recovery to >+2% organic growth in a single quarter would represent a significant inflection. No Polymarket market available; based on FY26 momentum and sector trends.